ÂÜÀòÂÒÂ×

Matthew Dunn's work experience includes various roles in the biotechnology industry.

From September 2022, they have been serving as the Vice President of Technology & IP at ArkeaBio. Prior to this role, they worked as a Scientific Consultant at the same company from February to September 2022.

Before joining ArkeaBio, Matthew worked as a Patent Agent at Storella & Witt, LLP, starting in September 2021. Matthew specialized in biotech and cleantech, helping technology companies develop and execute IP strategies.

In 2021, Matthew also worked as a Scientific Consultant & Patent Agent at Boulder Consulting Group, LLC.

In 2021, Matthew held the position of R&D Manager at Bio-Rad Laboratories, specifically in the Digital Biology Group. Here, they contributed to the development of a breakthrough technology called Droplet Digital PCR.

Matthew's experience also includes working at Dropworks, Inc. as the Director of Research and Development and Head of IP from December 2019 to October 2021. Matthew also served as a Principal Scientist at the same company from December 2018 to December 2019. Dropworks focused on creating a platform for performing biological assays in flowing droplets.

Before joining Dropworks, Matthew served as a Lead Protein Engineer at enEvolv from May to December 2018. Their responsibilities included engineering microorganisms to produce bio-based products.

Matthew's earlier work experience includes serving as a Postdoctoral Researcher at UC Irvine from October 2015 to December 2016. Their research focused on protein and nucleic acid engineering and evolution.

As a Graduate Student, Matthew worked on different research projects. At the Center for Personalized Diagnostics from November 2011 to October 2015, they developed engineered polymerases for practical applications in synthetic biology. Prior to that, at the Center for Biosignatures Discovery Analysis from May 2010 to November 2011, they conducted research on single-cell characterization using microfluidics and aptamer-bound DNA origami nanoarrays.

Matthew Dunn completed their Bachelor's Degree in Genetics, Cell, and Developmental Biology from Arizona State University, from the period of 2006 to 2010. Subsequently, they pursued a Doctor of Philosophy (Ph.D.) in Molecular and Cellular Biology at Arizona State University, accomplishing this degree from 2010 to 2015.